These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38917808)

  • 21. Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease.
    Fornelos N; Franzosa EA; Bishai J; Annand JW; Oka A; Lloyd-Price J; Arthur TD; Garner A; Avila-Pacheco J; Haiser HJ; Tolonen AC; Porter JA; Clish CB; Sartor RB; Huttenhower C; Vlamakis H; Xavier RJ
    Nat Microbiol; 2020 Mar; 5(3):486-497. PubMed ID: 31959971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Cox SR; Lindsay JO; Fromentin S; Stagg AJ; McCarthy NE; Galleron N; Ibraim SB; Roume H; Levenez F; Pons N; Maziers N; Lomer MC; Ehrlich SD; Irving PM; Whelan K
    Gastroenterology; 2020 Jan; 158(1):176-188.e7. PubMed ID: 31586453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
    Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
    Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution microbiota flow cytometry reveals dynamic colitis-associated changes in fecal bacterial composition.
    Zimmermann J; Hübschmann T; Schattenberg F; Schumann J; Durek P; Riedel R; Friedrich M; Glauben R; Siegmund B; Radbruch A; Müller S; Chang HD
    Eur J Immunol; 2016 May; 46(5):1300-3. PubMed ID: 26909672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
    Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
    Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linkage analysis identifies novel genetic modifiers of microbiome traits in families with inflammatory bowel disease.
    Sharma A; Szymczak S; Rühlemann M; Freitag-Wolf S; Knecht C; Enderle J; Schreiber S; Franke A; Lieb W; Krawczak M; Dempfle A
    Gut Microbes; 2022; 14(1):2024415. PubMed ID: 35129060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
    Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the gut microbiota in inflammatory bowel diseases: where are we?
    Benech N; Sokol H
    Curr Opin Microbiol; 2023 Aug; 74():102319. PubMed ID: 37062174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease.
    Guzzo GL; Andrews JM; Weyrich LS
    Inflamm Bowel Dis; 2022 Jul; 28(7):1112-1122. PubMed ID: 35092426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of Crohn's disease and ulcerative colitis using the microbiome.
    Kang DY; Park JL; Yeo MK; Kang SB; Kim JM; Kim JS; Kim SY
    BMC Microbiol; 2023 Nov; 23(1):336. PubMed ID: 37951857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota.
    Altomare A; Putignani L; Del Chierico F; Cocca S; Angeletti S; Ciccozzi M; Tripiciano C; Dalla Piccola B; Cicala M; Guarino MPL
    Dig Liver Dis; 2019 May; 51(5):648-656. PubMed ID: 30573380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faecal microRNA as a biomarker of the activity and prognosis of inflammatory bowel diseases.
    Ji Y; Li X; Zhu Y; Li N; Zhang N; Niu M
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2443-2450. PubMed ID: 29969632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory Bowel Disease-Associated Gut Commensals Degrade Components of the Extracellular Matrix.
    Porras AM; Zhou H; Shi Q; Xiao X; ; Longman R; Brito IL
    mBio; 2022 Dec; 13(6):e0220122. PubMed ID: 36445085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.
    Malham M; Lilje B; Houen G; Winther K; Andersen PS; Jakobsen C
    Scand J Gastroenterol; 2019 Aug; 54(8):969-975. PubMed ID: 31329473
    [No Abstract]   [Full Text] [Related]  

  • 35. Step-up fecal microbiota transplantation (FMT) strategy.
    Cui B; Li P; Xu L; Peng Z; Xiang J; He Z; Zhang T; Ji G; Nie Y; Wu K; Fan D; Zhang F
    Gut Microbes; 2016 Jul; 7(4):323-328. PubMed ID: 26939622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overrepresentation of Enterobacteriaceae and
    Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H
    Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.
    Carstens A; Dicksved J; Nelson R; Lindqvist M; Andreasson A; Bohr J; Tysk C; Talley NJ; Agréus L; Engstrand L; Halfvarson J
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00065. PubMed ID: 31343467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.
    Casén C; Vebø HC; Sekelja M; Hegge FT; Karlsson MK; Ciemniejewska E; Dzankovic S; Frøyland C; Nestestog R; Engstrand L; Munkholm P; Nielsen OH; Rogler G; Simrén M; Öhman L; Vatn MH; Rudi K
    Aliment Pharmacol Ther; 2015 Jul; 42(1):71-83. PubMed ID: 25973666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbiome-phage interactions in inflammatory bowel disease.
    Federici S; Kviatcovsky D; Valdés-Mas R; Elinav E
    Clin Microbiol Infect; 2023 Jun; 29(6):682-688. PubMed ID: 36191844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dispersal strategies shape persistence and evolution of human gut bacteria.
    Hildebrand F; Gossmann TI; Frioux C; Özkurt E; Myers PN; Ferretti P; Kuhn M; Bahram M; Nielsen HB; Bork P
    Cell Host Microbe; 2021 Jul; 29(7):1167-1176.e9. PubMed ID: 34111423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.